COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

Background and objectives: It is unclear how multiple sclerosis (MS) affects the severity of COVID-19. The aim of this study is to compare COVID-19-related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population. Methods: Hospitalization, intensive care unit (ICU) admission, and death after COVID-19 diagnosis of 1,362 patients with MS were compared with the age- and sex-matched Italian population in a retrospective observational case-cohort study with population-based control. The observed vs the expected events were compared in the whole MS cohort and in different subgroups (higher risk: Expanded Disability Status Scale [EDSS] score > 3 or at least 1 comorbidity, lower risk: EDSS score ≤ 3 and no comorbidities) by the χ2 test, and the risk excess was quantified by risk ratios (RRs). Results: The risk of severe events was about twice the risk in the age- and sex-matched Italian population: RR = 2.12 for hospitalization (p < 0.001), RR = 2.19 for ICU admission (p < 0.001), and RR = 2.43 for death (p < 0.001). The excess of risk was confined to the higher-risk group (n = 553). In lower-risk patients (n = 809), the rate of events was close to that of the Italian age- and sex-matched population (RR = 1.12 for hospitalization, RR = 1.52 for ICU admission, and RR = 1.19 for death). In the lower-risk group, an increased hospitalization risk was detected in patients on anti-CD20 (RR = 3.03, p = 0.005), whereas a decrease was detected in patients on interferon (0 observed vs 4 expected events, p = 0.04). Discussion: Overall, the MS cohort had a risk of severe events that is twice the risk than the age- and sex-matched Italian population. This excess of risk is mainly explained by the EDSS score and comorbidities, whereas a residual increase of hospitalization risk was observed in patients on anti-CD20 therapies and a decrease in people on interferon

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France

We evaluated the effect of DMTs on Covid-19 severity in patients with MS, with a pooled-analysis of two large cohorts from Italy and France. The association of baseline characteristics and DMTs with Covid-19 severity was assessed by multivariate ordinal-logistic models and pooled by a fixed-effect meta-analysis. 1066 patients with MS from Italy and 721 from France were included. In the multivariate model, anti-CD20 therapies were significantly associated (OR = 2.05, 95%CI = 1.39–3.02, p < 0.001) with Covid-19 severity, whereas interferon indicated a decreased risk (OR = 0.42, 95%CI = 0.18–0.99, p = 0.047). This pooled-analysis confirms an increased risk of severe Covid-19 in patients on anti-CD20 therapies and supports the protective role of interferon

Zoetrope Genetic Programming for Regression

International audienceThe Zoetrope Genetic Programming (ZGP) algorithm is based on an original representation for mathematical expressions, targeting evolutionary symbolic regression. The zoetropic representation uses repeated fusion operations between partial expressions, starting from the terminal set. Repeated fusions within an individual gradually generate more complex expressions, ending up in what can be viewed as new features. These features are then linearly combined to best fit the training data. ZGP individuals then undergo specific crossover and mutation operators, and selection takes place between parents and offspring. ZGP is validated using a large number of public domain regression datasets, and compared to other symbolic regression algorithms, as well as to traditional machine learning algorithms. ZGP reaches state-of-theart performance with respect to both types of algorithms, and demonstrates a low computational time compared to other symbolic regression approaches

Zoetrope Genetic Programming for Regression

International audienceThe Zoetrope Genetic Programming (ZGP) algorithm is based on an original representation for mathematical expressions, targeting evolutionary symbolic regression. The zoetropic representation uses repeated fusion operations between partial expressions, starting from the terminal set. Repeated fusions within an individual gradually generate more complex expressions, ending up in what can be viewed as new features. These features are then linearly combined to best fit the training data. ZGP individuals then undergo specific crossover and mutation operators, and selection takes place between parents and offspring. ZGP is validated using a large number of public domain regression datasets, and compared to other symbolic regression algorithms, as well as to traditional machine learning algorithms. ZGP reaches state-of-theart performance with respect to both types of algorithms, and demonstrates a low computational time compared to other symbolic regression approaches

Zoetrope Genetic Programming for Regression

International audienceThe Zoetrope Genetic Programming (ZGP) algorithm is based on an original representation for mathematical expressions, targeting evolutionary symbolic regression. The zoetropic representation uses repeated fusion operations between partial expressions, starting from the terminal set. Repeated fusions within an individual gradually generate more complex expressions, ending up in what can be viewed as new features. These features are then linearly combined to best fit the training data. ZGP individuals then undergo specific crossover and mutation operators, and selection takes place between parents and offspring. ZGP is validated using a large number of public domain regression datasets, and compared to other symbolic regression algorithms, as well as to traditional machine learning algorithms. ZGP reaches state-of-theart performance with respect to both types of algorithms, and demonstrates a low computational time compared to other symbolic regression approaches